Douglas Forsyth - Net Worth and Insider Trading
Douglas Forsyth Net Worth
The estimated net worth of Douglas Forsyth is at least $4 Million dollars as of 2024-09-20. Douglas Forsyth is the Director of Inhibrx Biosciences Inc and owns about 224,564 shares of Inhibrx Biosciences Inc (INBX) stock worth over $4 Million. Douglas Forsyth is also the Affiliated Person of Virtus AllianzGI Equity & Convertible Income Fund and owns about 0 shares of Virtus AllianzGI Equity & Convertible Income Fund (NIE) stock worth over $0. Details can be seen in Douglas Forsyth's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Douglas Forsyth has not made any transactions after 2024-08-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Douglas Forsyth
Douglas Forsyth Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Douglas Forsyth owns 11 companies in total, including Inhibrx Inc (INBX) , Virtus AllianzGI Equity & Convertible Income Fund (NIE) , and Virtus Convertible & Income 2024 Target Term Fund (CBH) among others .
Click here to see the complete history of Douglas Forsyth’s form 4 insider trades.
Insider Ownership Summary of Douglas Forsyth
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INBX | Inhibrx Inc | 2020-08-18 | director |
| NIE | Virtus AllianzGI Equity & Convertible Income Fund | 2020-08-11 | other: Affiliated Person |
| CBH | Virtus Convertible & Income 2024 Target Term Fund | 2017-06-27 | other: Portfolio Manager |
 | | 2015-05-21 | other: Affiliated Person |
| | 2007-08-15 | other: Affiliated Person |
| | 2014-03-13 | other: Affiliated Person |
| | 2014-02-21 | other: Affiliated Person |
| | 2013-04-01 | other: Affiliated Person |
| | 2005-02-23 | other: Portfolio Manager |
| | 2003-07-30 | Vice President/Portfolio Mgr. |
| | 2007-08-15 | other: Affiliated Person |
Douglas Forsyth Latest Holdings Summary
Douglas Forsyth currently owns a total of 2 stocks. Among these stocks, Douglas Forsyth owns 224,564 shares of Inhibrx Biosciences Inc (INBX) as of August 23, 2024, with a value of $4 Million and a weighting of 100%. Douglas Forsyth also owns 0 shares of Virtus AllianzGI Equity & Convertible Income Fund (NIE) as of August 11, 2020, with a value of $0 and a weighting of 0%.
Latest Holdings of Douglas Forsyth
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INBX | Inhibrx Biosciences Inc | 2024-08-23 | 224,564 | 16.81 | 3,774,921 |
| NIE | Virtus AllianzGI Equity & Convertible Income Fund | 2020-08-11 | 0 | 22.72 | 0 |
Holding Weightings of Douglas Forsyth
Douglas Forsyth Form 4 Trading Tracker
According to the SEC Form 4 filings, Douglas Forsyth has made a total of 1 transactions in Inhibrx Biosciences Inc (INBX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Inhibrx Biosciences Inc is the acquisition of 75,000 shares on August 23, 2024, which cost Douglas Forsyth around $1 Million.
According to the SEC Form 4 filings, Douglas Forsyth has made a total of 1 transactions in Virtus AllianzGI Equity & Convertible Income Fund (NIE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Virtus AllianzGI Equity & Convertible Income Fund is the sale of 20,000 shares on August 11, 2020, which brought Douglas Forsyth around $493,200.
Insider Trading History of Douglas Forsyth
- 1
Douglas Forsyth Trading Performance
GuruFocus tracks the stock performance after each of Douglas Forsyth's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas Forsyth is %. GuruFocus also compares Douglas Forsyth's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas Forsyth within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Douglas Forsyth's insider trading performs compared to the benchmark.
Performance of Douglas Forsyth
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 31.18 | | | | | |
| Relative Return to S&P 500(%) | 29.78 | | | | | |
Douglas Forsyth Ownership Network
Douglas Forsyth Owned Company Details
What does Inhibrx Inc do?
Who are the key executives at Inhibrx Inc?
Douglas Forsyth is the director of Inhibrx Inc. Other key executives at Inhibrx Inc include director & 10 percent owner & Chief Scientific Officer Brendan P. Eckelman , 10 percent owner Ole Andreas Halvorsen , and 10 percent owner Viking Global Opportunities Parent Gp Llc .
Inhibrx Inc (INBX) Insider Trades Summary
Over the past 18 months, Douglas Forsyth made no insider transaction in Inhibrx Inc (INBX). Other recent insider transactions involving Inhibrx Inc (INBX) include a net purchase of 511,627 shares made by Viking Global Investors Lp , and a net sale of 300,000 shares made by Brendan P. Eckelman .
In summary, during the past 3 months, insiders sold 0 shares of Inhibrx Inc (INBX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 300,000 shares of Inhibrx Inc (INBX) were sold and 511,627 shares were bought by its insiders, resulting in a net purchase of 211,627 shares.
Inhibrx Inc (INBX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inhibrx Inc Insider Transactions
Douglas Forsyth Mailing Address
Above is the net worth, insider trading, and ownership report for Douglas Forsyth. You might contact Douglas Forsyth via mailing address: 1633 Broadway, New York Ny 10019.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
